1:10,000 (0.1 mg/mL)
Fliptop Vial Rx only
Protect solution from light;
do not use the Injection if its color is pinkish or darker than slightly yellow or if it contains a precipitate. Epinephrine Injection, USP is a sterile, nonpyrogenic solution administered parenterally by the intravenous or intracardiac (left ventricular chamber) routes, or via endotracheal tube into the
Epinephrine Injection, USP is indicated for intravenous injection in (1) treatment of acute hypersensitivity (anaphylactoid reactions to drugs, animal serums and other allergens), (2) treatment of acute asthmatic attacks to relieve bronchospasm not controlled by inhalation or subcutaneous administration of other solutions of the drug and (3) treatment and prophylaxis of cardiac arrest and attacks of transitory atrioventricular (A-V) heart block with syncopal seizures (Stokes-Adams Syndrome). In acute attacks of ventricular standstill, physical measures should be applied first. When external cardiac compression and attempts to restore the circulation by electrical defibrillation or use of a pacemaker fail, intracardiac puncture and intramyocardial injection of epinephrine may be effective.
Media Articles Related to Ephinephrine Injection (Epinephrine Injection)
Source: MedicineNet Allergic Cascade Specialty [2015.06.24]
Category: Diseases and Conditions
Created: 4/15/2000 12:00:00 AM
Last Editorial Review: 6/24/2015 12:00:00 AM
Study shows second severe allergic reaction can occur hours after first
Source: Allergy News From Medical News Today [2015.07.08]
Affects almost 15 percent of kidsParents of kids with severe allergies know how scary a severe allergic reaction (anaphylaxis) is.
Emergency visits for childhood food allergy on rise in Illinois
Source: Allergy News From Medical News Today [2015.06.26]
Visits for anaphylaxis climb 29 percent, Hispanic children's visits up 44 percent Food allergies now impacting children of all races and incomes Hispanic children have highest rise...
Published Studies Related to Ephinephrine Injection (Epinephrine Injection)
Faster onset and more comfortable injection with alkalinized 2% lidocaine with
epinephrine 1:100,000. 
(IANBs)... CONCLUSIONS: Alkalinizing lidocaine with epinephrine toward physiologic pH
A comparison of the efficacy of 4% articaine with 1:100,000 epinephrine and 2%
lidocaine with 1:80,000 epinephrine in achieving pulpal anesthesia in maxillary
teeth with irreversible pulpitis. 
anesthesia in maxillary teeth with irreversible pulpitis... CONCLUSIONS: There was no significant difference in efficacy between 4% articaine
Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgia. [2011.05]
OBJECTIVE: The objective of this study was to evaluate the effect of intravenous lidocaine combined with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine levels... CONCLUSIONS: Combined administration of 240 mg intravenous lidocaine (once a week) and 25 mg amitriptyline for 4 weeks did not modify pain intensity or plasma serotonin, norepinephrine, or dopamine concentrations in fibromyalgia patients.
Anesthetic efficacy of 4% Articaine with 1:100,000 epinephrine versus 4% articaine with 1:200,000 epinephrine as a primary buccal infiltration in the mandibular first molar. [2011.04]
INTRODUCTION: No study has compared 4% articaine with 1:100,000 epinephrine with 4% articaine with 1:200,000 epinephrine in a mandibular buccal infiltration of the first molar. The authors conducted a prospective, randomized, double-blind, crossover study comparing the degree of pulpal anesthesia obtained with 4% articaine with 1:100,000 epinephrine and 4% articaine with 1:200,000 epinephrine as a primary infiltration in the mandibular first molar... CONCLUSIONS: The anesthetic efficacy of 4% articaine with 1:200,000 epinephrine is comparable to 4% articaine with 1:100,000 epinephrine in a primary mandibular buccal infiltration of the first molar. Copyright (c) 2011 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.
Does preincisional injection of levobupivacaine with epinephrine have any benefits for children undergoing tonsillectomy? An intraindividual evaluation. [2010.10]
OBJECTIVE: To evaluate the effects of peritonsillar injection of levobupivacaine with epinephrine in children undergoing adenotonsillectomy, through an intraindividual study... CONCLUSION: Preincisional injection of levobupivacaine with epinephrine decreases early postoperative pain and intraoperative blood loss as well. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.
Clinical Trials Related to Ephinephrine Injection (Epinephrine Injection)
Hemostasis During Hypospadias Surgery [Recruiting]
A comparison between the two hemostatic methods of hypospadias repairing operation, in
terms of early and mid-term (up to 6 months) failure rate (wound dehiscence and urethral
stricture needing reoperation) between the two groups: Group A) diluted Epinephrine
injection, Group B) tourniquet application in children
Efficacy of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy [Recruiting]
To assess the pain relief and the hemodynamic stability of ropivacaine with epinephrine in
BABA endoscopic and robotic thyroidectomy.
Optimal Time Delay of Epinephrine Injection With "One-per-mil" Tumescent Solution [Enrolling by invitation]
The aim of this study is to know the characteristic of "one-per-mil" tumescent solution in
regards of the optimal time delay to achieve optimal visualization of operation field in
hand and digit surgery.
1. Epinephine in "one-per-mil" concentration by tumescent injection technique will provide
faster decrease in oxygen saturation compared to normal saline solution injected by
2. Epinephrine in "one-per-mil" concentration by tumescent injection technique will
provide effectiveness in vasoconstriction longer than 10 minutes as the optimal time
3. Epinephine in "one-per-mil" concentration by tumescent injection technique causes no
finger necrosis as normal saline solution injected by tumescent technique.
Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps for Acute Peptic Ulcer Bleeding [Recruiting]
Endoscopic high-frequency soft coagulation is available for the management of bleeding or
nonbleeding visible vessels during endoscopic submucosal dissection. However, its efficacy
on peptic ulcer bleeding has not been elucidated so far. The aim of this study was to
evaluate the efficacy of hemostasis with soft coagulation using hemostatic forceps by
comparing it with argon plasma coagulation (APC) in a prospective, randomized trial.
Second-look Endoscopy in High Risk Patients After Endoscopic Hemostasis to Their Bleeding Peptic Ulcers Improves Their Outcomes [Recruiting]
Bleeding peptic ulcer is a common medical emergency. Endoscopic treatment stops bleeding in
those actively bleeding from their peptic ulcers, reduces further bleeding, transfusion,
surgery and deaths. After initial endoscopic control of bleeding, approximately 10% of them
will develop recurrent bleeding. Mortality rate in this group of patients is at least 4 fold
higher. In the few who need surgery, mortality approaches 30%. Prevention of further
bleeding is therefore a major treatment objective. Currently the investigators use a high
dose infusion of proton pump inhibitor (PPI) for 72 hours to render gastric pH neutral. In a
previous randomized trial, the investigators showed that the rate of bleeding in 30 days was
around 7% with such an approach. In a small subgroup of high risk patients defined by
presentation with shock and ulcers > 2 cm in size, 1 in 6 would re-bleed. An alternate
strategy is to select those at especially high risk of further bleeding and repeat
endoscopic treatment the next morning. The investigators have shown that persistence of
major bleeding stigmata, i. e. a visible vessel, during a second endoscopy predicts further
bleeding. It is therefore logical that by repeating endoscopic treatment the next morning,
the investigators can prevent further bleeding and possibly surgery and deaths. The current
study proposes to develop a score to identify those at risk of further bleeding after
endoscopy. The investigators used a historical cohort with carefully collected clinical data
to derive a risk score. In this derivation phase of 939 patients, the investigators have
developed a 9 point risk score which consists of the following parameters (Age>60, Male sex,
ulcer>2cm, posterior bulbar in location, spurting or Forrest Ia bleeding and admission
hemoglobin of < 8 g/dl). Using AUROC and Youden J statistics, a score of 5 or above has been
shown to highly predictive of further bleeding. The score will then be validated in a
prospective cohort of patients with bleeding peptic ulcers. In the final phase of this
study, the investigators propose a randomized controlled trial to test the hypothesis that a
second look endoscopy with treatment in selected high risk patients can further reduce
bleeding and improve their outcomes. After endoscopic hemostasis to their bleeding peptic
ulcers, patients are risk stratified based on the score. Those with a score of 5 or more are
randomized to receive the standard treatment (a high dose PPI infusion) or a second look
endoscopy with treatment in addition to PPI infusion. The primary outcome to the trial is
further significant clinical bleeding.
Page last updated: 2015-07-08